Insufficient scRNA-seq data for expression of TRIM72 at single-cell level.
Insufficient scRNA-seq data for expression of TRIM72 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 13910.92 | 803 / 803 | 0% | 0 | 0 / 0 |
brain | 93% | 497.20 | 2457 / 2642 | 0% | 0.01 | 3 / 705 |
heart | 70% | 62.12 | 604 / 861 | 0% | 0 | 0 / 0 |
skin | 64% | 35.66 | 1158 / 1809 | 1% | 0.24 | 7 / 472 |
intestine | 40% | 11.00 | 382 / 966 | 18% | 1.53 | 97 / 527 |
breast | 33% | 18.14 | 152 / 459 | 11% | 1.19 | 128 / 1118 |
spleen | 43% | 10.85 | 103 / 241 | 0% | 0 | 0 / 0 |
esophagus | 33% | 17.82 | 474 / 1445 | 10% | 0.43 | 18 / 183 |
thymus | 38% | 17.73 | 250 / 653 | 1% | 0.08 | 6 / 605 |
stomach | 20% | 4.89 | 72 / 359 | 16% | 1.02 | 45 / 286 |
prostate | 28% | 111.77 | 69 / 245 | 5% | 0.35 | 25 / 502 |
adipose | 33% | 10.82 | 393 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 32% | 23.10 | 293 / 929 | 0% | 0 | 0 / 0 |
kidney | 28% | 8.53 | 25 / 89 | 2% | 0.39 | 15 / 901 |
lung | 18% | 4.93 | 106 / 578 | 10% | 0.75 | 114 / 1155 |
uterus | 18% | 4.20 | 31 / 170 | 10% | 1.69 | 44 / 459 |
blood vessel | 25% | 13.10 | 331 / 1335 | 0% | 0 | 0 / 0 |
bladder | 14% | 4.05 | 3 / 21 | 8% | 0.69 | 41 / 504 |
tonsil | 0% | 0 | 0 / 0 | 22% | 1.05 | 10 / 45 |
ovary | 22% | 5.65 | 39 / 180 | 0% | 0.00 | 1 / 430 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.67 | 3 / 29 |
liver | 4% | 0.97 | 10 / 226 | 3% | 0.28 | 13 / 406 |
pancreas | 2% | 0.47 | 6 / 328 | 2% | 0.07 | 4 / 178 |
adrenal gland | 3% | 1.76 | 7 / 258 | 1% | 0.02 | 2 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0051260 | Biological process | protein homooligomerization |
GO_0016567 | Biological process | protein ubiquitination |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0010832 | Biological process | negative regulation of myotube differentiation |
GO_0003012 | Biological process | muscle system process |
GO_0006887 | Biological process | exocytosis |
GO_0007517 | Biological process | muscle organ development |
GO_0043569 | Biological process | negative regulation of insulin-like growth factor receptor signaling pathway |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0042383 | Cellular component | sarcolemma |
GO_0005737 | Cellular component | cytoplasm |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0031435 | Molecular function | mitogen-activated protein kinase kinase kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
Gene name | TRIM72 |
Protein name | Tripartite motif-containing protein 72 (Mitsugumin-53) (Mg53) |
Synonyms | MG53 |
Description | FUNCTION: Muscle-specific protein that plays a central role in cell membrane repair by nucleating the assembly of the repair machinery at injury sites. Specifically binds phosphatidylserine. Acts as a sensor of oxidation: upon membrane damage, entry of extracellular oxidative environment results in disulfide bond formation and homooligomerization at the injury site. This oligomerization acts as a nucleation site for recruitment of TRIM72-containing vesicles to the injury site, leading to membrane patch formation. Probably acts upstream of the Ca(2+)-dependent membrane resealing process. Required for transport of DYSF to sites of cell injury during repair patch formation. Regulates membrane budding and exocytosis. May be involved in the regulation of the mobility of KCNB1-containing endocytic vesicles (By similarity). . |
Accessions | ENST00000322122.8 [Q6ZMU5-1] Q6ZMU5 |